How to Choose a Psilocybin Retreat: Green Flags and Red Flags

From the outside, psilocybin retreats can look alike. The differences that matter are often in the detail: who screens you, who is in the room during the session, and what support you have afterward. This checklist covers the green flags to look for, the red flags to take seriously, and the questions worth asking before you book.

What should a good psilocybin retreat include?

A good retreat puts your safety ahead of filling places. Look for real medical and psychological screening, a willingness to say no, named and qualified facilitators, enough staff in the room, clear prices and policies, an emergency plan, and structured preparation and integration around the sessions themselves.

The green flags:

• Screening that takes time. Expect questions about your medical history, current and past medications, mental health history and family history, and a conversation about why you want to come. A long intake is a good sign.
• A willingness to decline applicants. Ask how often they say no. A program that accepts everyone isn't really screening.
• Named, qualified facilitators. You should be able to see full names, training and backgrounds before you book. A team that mixes clinical, research and hands-on psilocybin experience is a strong sign.
• Enough staff in the room. One facilitator can't look after a dozen guests. Ask for the ratio. At Beckley there is at least one facilitator for every four guests.
• Trust built before the session. Safety guidelines for psilocybin research stress building rapport between guests and facilitators well before the session begins.
• Transparency from pricing to preparation. Clear prices, written policies, consent forms and medical releases, and direct answers to direct questions.
• A plan for emergencies. Medical cover, crisis protocols and a clear answer to "what happens if a session gets difficult?"
• Preparation before and integration after. The weeks around the retreat matter as much as the sessions. Look for structured support on both sides: group calls, one to one sessions, journaling, meditation, time in nature.

Where are psilocybin retreats legal?

Choose a program that operates where this work is permitted. Jamaica is one of the few jurisdictions where this work is fully permitted, and Beckley's Netherlands programs run under Dutch legal frameworks. In the United States psilocybin remains federally illegal. Ask any retreat which country's law it operates under, and expect a clear answer.

What questions should you ask before you book?

Ask as many questions as you need to understand how the program keeps you safe. A good team answers clearly and never makes you feel like a nuisance. If you are rushed or brushed off, take that as your answer.

• How do you screen guests, and how often do you decline applicants?
• What does the medical screening cover, and why?
• Who are the facilitators, and what is their training?
• How many guests does each facilitator look after?
• What happens if a guest has a difficult session?
• What preparation and integration support is included, and how is it structured?
• Which country's law do you operate under?

What are the red flags?

One red flag can be a misunderstanding. Several together are a reason to walk away. Watch for promises that sound too good, a casual attitude to risk, facilitators you can't look up, and pressure to book quickly.

• Promised outcomes. Claims that the program will fix depression, trauma or anything else, for everyone. No responsible program promises results.
• Playing down risk. Psilocybin is powerful and isn't right for everyone. A program that says there is no risk, or skips over side effects, isn't being straight with you.
• Little or no screening. If nobody asks about your health, medications and history, look elsewhere.
• One approach for everyone. The same protocol for every guest, with no personal plan.
• Facilitators you can't verify. No full names, training or backgrounds.
• Too few staff. Large groups with one or two facilitators.
• Pressure to book. Countdown timers, limited time offers and pushy follow-ups.
• Vague policies. Nothing in writing about consent, medical releases, cancellations or what is included.
• Silence before you travel. You should hear from the team regularly in the weeks before you arrive.
• Reviews that only mention luxury. If guests praise the pool and say little about the care, notice that.
• No support afterward, or support designed to keep you dependent on the program.

Why do preparation and integration matter as much as the session?

The sessions last hours. What you do in the weeks before and after shapes what you take home. Research on harm reduction counts preparation and integration as core parts of a safe experience, not extras.

A good program prepares you before you arrive, stays with you through the sessions, and helps you turn what came up into changes you can keep. If everything outside the sessions feels like an afterthought, be skeptical.

Clinical trials are studying psilocybin for conditions such as:

• Major depressive disorder
• Treatment-resistant depression
• Anxiety, ADHD and PTSD
• Compulsive behaviors and addiction
• Burnout

That research takes place in clinical settings, and a retreat is not a treatment. Our research hub explains what the studies show and what they don't.

How Beckley approaches this

Every Beckley guest goes through screening and a mandatory suitability call. Each retreat has at least one facilitator for every four guests, with online preparation before you arrive and integration support after. To see how the program works, start with our program.

Frequently Asked Questions

Sources

1. Neitzke-Spruill L, Beit CS, Robinson JO, Singh N, Kambala S, Ramesh R, McGuire AL. A landscape analysis of psychedelic retreat organizations advertising online. PLoS One. 2025 May 2;20(5):e0321648. doi: 10.1371/journal.pone.0321648. PMID: 40315211; PMCID: PMC12047835.
2. Johnson M, Richards W, Griffiths R. Human hallucinogen research: guidelines for safety. J Psychopharmacol. 2008 Aug;22(6):603-20. doi: 10.1177/0269881108093587. Epub 2008 Jul 1. PMID: 18593734; PMCID: PMC3056407.
3. Gorman I, Nielson EM, Molinar A, Cassidy K, Sabbagh J. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. Front Psychol. 2021 Mar 15;12:645246. doi: 10.3389/fpsyg.2021.645246. PMID: 33796055; PMCID: PMC8008322.

Sources

1. data (pmc.ncbi.nlm.nih.gov). https://pmc.ncbi.nlm.nih.gov/articles/PMC12047835/
2. shows (pubmed.ncbi.nlm.nih.gov). https://pubmed.ncbi.nlm.nih.gov/18593734/
3. regards (pubmed.ncbi.nlm.nih.gov). https://pubmed.ncbi.nlm.nih.gov/33796055/